{"id":7501,"date":"2026-05-10T15:20:00","date_gmt":"2026-05-10T13:20:00","guid":{"rendered":"https:\/\/ksbbiotech.com\/?page_id=7501"},"modified":"2026-06-03T10:59:45","modified_gmt":"2026-06-03T08:59:45","slug":"ctnl-bnp-d-dimer","status":"publish","type":"page","link":"https:\/\/ksbbiotech.com\/zh\/ctnl-bnp-d-dimer\/","title":{"rendered":"\u5fc3\u808c\u808c\u9499\u86cb\u767d\u3001B\u578b\u5229\u94a0\u80bd\u3001D-\u4e8c\u805a\u4f53\uff08\u4e09\u5408\u4e00\uff09"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Cardiac Troponin, B-Type Natriuretic Peptide, D-dimer (3 in 1)<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

PDB ID: 1J1E, 1YK1, 2Q9I. Source: RCSB Protein Data Bank. For illustration purposes only.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t\t

VeriLumenTM<\/sup> cTnI+BNP+D-Dimer<\/span>
<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The VeriLumenTM<\/sup> Cardiac Troponin I, B-Type Natriuretic Peptide & D-Dimer Rapid Test is a fluorescence immunochromatographic assay for the quantitative detection of cardiac troponin I (cTnI), B-type natriuretic peptide (BNP), and D-dimer in human whole blood or plasma samples. These biomarkers are associated with different cardiovascular and thrombotic conditions, allowing simultaneous assessment of myocardial injury, cardiac dysfunction, and coagulation activity. The assay provides rapid quantitative results to support timely clinical evaluation in laboratory and point-of-care settings.<\/p>

cTnI is primarily used in the clinical assessment and auxiliary diagnosis of myocardial infarction, while BNP is commonly used in the evaluation of heart failure and cardiac stress. D-dimer is widely used in the assessment of coagulation and thrombotic disorders, including disseminated intravascular coagulation (DIC), thrombolytic therapy monitoring, and evaluation of suspected venous thromboembolic conditions. Combined quantitative measurement of these three biomarkers supports comprehensive cardiovascular assessment when interpreted together with clinical findings and other diagnostic information.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t